These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
333 related articles for article (PubMed ID: 15213293)
1. Modulation of the cellular pharmacology of cisplatin and its analogs by the copper exporters ATP7A and ATP7B. Samimi G; Katano K; Holzer AK; Safaei R; Howell SB Mol Pharmacol; 2004 Jul; 66(1):25-32. PubMed ID: 15213293 [TBL] [Abstract][Full Text] [Related]
2. Modulation of the cellular pharmacology of JM118, the major metabolite of satraplatin, by copper influx and efflux transporters. Samimi G; Howell SB Cancer Chemother Pharmacol; 2006 Jun; 57(6):781-8. PubMed ID: 16170571 [TBL] [Abstract][Full Text] [Related]
3. Increased expression of the copper efflux transporter ATP7A mediates resistance to cisplatin, carboplatin, and oxaliplatin in ovarian cancer cells. Samimi G; Safaei R; Katano K; Holzer AK; Rochdi M; Tomioka M; Goodman M; Howell SB Clin Cancer Res; 2004 Jul; 10(14):4661-9. PubMed ID: 15269138 [TBL] [Abstract][Full Text] [Related]
4. Role of copper transporters in resistance to platinating agents. Rabik CA; Maryon EB; Kasza K; Shafer JT; Bartnik CM; Dolan ME Cancer Chemother Pharmacol; 2009 Jun; 64(1):133-42. PubMed ID: 18998134 [TBL] [Abstract][Full Text] [Related]
5. Factors affecting sensitivity to antitumor platinum derivatives of human colorectal tumor cell lines. Kitada N; Takara K; Minegaki T; Itoh C; Tsujimoto M; Sakaeda T; Yokoyama T Cancer Chemother Pharmacol; 2008 Sep; 62(4):577-84. PubMed ID: 18030470 [TBL] [Abstract][Full Text] [Related]
6. Sensitization of cancer cells towards Cisplatin and Carboplatin by protein kinase D inhibitors through modulation of ATP7A/B (copper transport ATPases). Janardhanan P; Somasundaran AK; Balakrishnan AJ; Pilankatta R Cancer Treat Res Commun; 2022; 32():100613. PubMed ID: 35908410 [TBL] [Abstract][Full Text] [Related]
7. Confocal microscopic analysis of the interaction between cisplatin and the copper transporter ATP7B in human ovarian carcinoma cells. Katano K; Safaei R; Samimi G; Holzer A; Tomioka M; Goodman M; Howell SB Clin Cancer Res; 2004 Jul; 10(13):4578-88. PubMed ID: 15240550 [TBL] [Abstract][Full Text] [Related]
8. Altered localisation of the copper efflux transporters ATP7A and ATP7B associated with cisplatin resistance in human ovarian carcinoma cells. Kalayda GV; Wagner CH; Buss I; Reedijk J; Jaehde U BMC Cancer; 2008 Jun; 8():175. PubMed ID: 18565219 [TBL] [Abstract][Full Text] [Related]
9. Sec61β controls sensitivity to platinum-containing chemotherapeutic agents through modulation of the copper-transporting ATPase ATP7A. Abada PB; Larson CA; Manorek G; Adams P; Howell SB Mol Pharmacol; 2012 Sep; 82(3):510-20. PubMed ID: 22710939 [TBL] [Abstract][Full Text] [Related]
10. Copper transporters regulate the cellular pharmacology and sensitivity to Pt drugs. Safaei R; Howell SB Crit Rev Oncol Hematol; 2005 Jan; 53(1):13-23. PubMed ID: 15607932 [TBL] [Abstract][Full Text] [Related]
11. Annexin A4-conferred platinum resistance is mediated by the copper transporter ATP7A. Matsuzaki S; Enomoto T; Serada S; Yoshino K; Nagamori S; Morimoto A; Yokoyama T; Kim A; Kimura T; Ueda Y; Fujita M; Fujimoto M; Kanai Y; Kimura T; Naka T Int J Cancer; 2014 Apr; 134(8):1796-809. PubMed ID: 24150977 [TBL] [Abstract][Full Text] [Related]
12. Translocation of platinum anticancer drugs by human copper ATPases ATP7A and ATP7B. Tadini-Buoninsegni F; Bartolommei G; Moncelli MR; Inesi G; Galliani A; Sinisi M; Losacco M; Natile G; Arnesano F Angew Chem Int Ed Engl; 2014 Jan; 53(5):1297-301. PubMed ID: 24375922 [TBL] [Abstract][Full Text] [Related]
13. Copper transporters and the cellular pharmacology of the platinum-containing cancer drugs. Howell SB; Safaei R; Larson CA; Sailor MJ Mol Pharmacol; 2010 Jun; 77(6):887-94. PubMed ID: 20159940 [TBL] [Abstract][Full Text] [Related]
14. The expression of copper transporters associated with the ototoxicity induced by platinum-based chemotherapeutic agents. Perde-Schrepler M; Fischer-Fodor E; Virag P; Brie I; Cenariu M; Pop C; Valcan A; Gurzau E; Maniu A Hear Res; 2020 Mar; 388():107893. PubMed ID: 32006874 [TBL] [Abstract][Full Text] [Related]
15. The roles of copper transporters in cisplatin resistance. Kuo MT; Chen HH; Song IS; Savaraj N; Ishikawa T Cancer Metastasis Rev; 2007 Mar; 26(1):71-83. PubMed ID: 17318448 [TBL] [Abstract][Full Text] [Related]
16. Role of human copper transporter Ctr1 in the transport of platinum-based antitumor agents in cisplatin-sensitive and cisplatin-resistant cells. Song IS; Savaraj N; Siddik ZH; Liu P; Wei Y; Wu CJ; Kuo MT Mol Cancer Ther; 2004 Dec; 3(12):1543-9. PubMed ID: 15634647 [TBL] [Abstract][Full Text] [Related]
17. Acquisition of resistance to cisplatin is accompanied by changes in the cellular pharmacology of copper. Katano K; Kondo A; Safaei R; Holzer A; Samimi G; Mishima M; Kuo YM; Rochdi M; Howell SB Cancer Res; 2002 Nov; 62(22):6559-65. PubMed ID: 12438251 [TBL] [Abstract][Full Text] [Related]
18. Increase in expression of the copper transporter ATP7A during platinum drug-based treatment is associated with poor survival in ovarian cancer patients. Samimi G; Varki NM; Wilczynski S; Safaei R; Alberts DS; Howell SB Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5853-9. PubMed ID: 14676106 [TBL] [Abstract][Full Text] [Related]
19. Differential expression of ATP7A, ATP7B and CTR1 in adult rat dorsal root ganglion tissue. Ip V; Liu JJ; Mercer JF; McKeage MJ Mol Pain; 2010 Sep; 6():53. PubMed ID: 20836889 [TBL] [Abstract][Full Text] [Related]
20. Mechanism of tumor resistance to cisplatin mediated by the copper transporter ATP7B. Dmitriev OY Biochem Cell Biol; 2011 Apr; 89(2):138-47. PubMed ID: 21455266 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]